St. Petersberg [Russia], April 27 (ANI/Sputnik): On Tuesday in St. Petersburg, Russian biotechnological company BioPalette launched the mass production of "MultiSCREEN," the world's first test system designed to simultaneously screen for the presence of such diseases as HIV, hepatitis B and C, and syphilis.